|Title:||Review of patient experiences of receiving biologic therapy in Cork University Hospital during COVID18 pandemic.|
|Author(s):||Maher A Casey D Murphy J Plant BJ Murphy D|
|Institution:||Cork University Hospital|
|Poster:||Click to view poster|
|Abstract:||We reviewed patients receiving biologic treatment for brittle asthma and assessed their experience of therapy in CUH during COVID-19 using the Hospital Anxiety and Depression Scale (HADS). |
56 patients were eligible to take part in this study. They were contacted by the respiratory nurse specialist and asked to complete the HADS questionnaire in July 2020. Patients were asked about their experiences in relation to receiving infusions during COVID-19.
53/56 questionnaires were completed and analysed. 92.4% of patients continued biologic therapy throughout the pandemic. Those that did not attend appointments had safety concerns. 20% of patients exacerbated during COVID-19 and there was one case of COVID-19. 22% of patients reported having a pre-morbid history of anxiety and/or depression. The HADs scale highlighted 32% of people had anxiety while 7.5% of patients had a score in keeping with depression.
Overall, the vast majority of this cohort of patients were happy to date with their care during the COVID-19 pandemic.